Manka, J. T.; Rodriguez, A. L.; Morrison, R. D.; Venable, D. F.; Cho, H. P.; Blobaum, A. L.; Daniels, J. S.; Niswender, C. M.; Conn, P. J.; Lindsley, C. W.; Emmitte, K. A.; Bioorg. Med. Chem. Lett., 2013, 23(18), 5091-5096
Mitigation of cardiovascular toxicity in a series of CSF-1R inhibitors, and the identification of AZD7507
Scott, D. A.; Dakin, L. A.; Daly, K.; Del Valle, D. J.; Diebold, R. B.; Drew, L.; Ezhuthachan, J.; Gero, T. W.; Ogoe, C. A.; Omer, C. A.; Redmond, S. P.; Repik, G.; Thakur, K.; Ye, Q.; Zheng, X.; Bioorg. Med. Chem. Lett., 2013, 23, 4591-4596
Important industrial procedures revisited in flow: very efficient oxidation and N-alkylation reactions with high atom-economy
Sipos, G.; Gyollai, V.; Dorman, G.; Kocsis, L.; Jones, R. V.; Darvas, F.; Journal of Flow Chemistry, 2013, 3(2), 51-58
First example of alkyl–aryl Negishi cross-coupling in flow: Mild, efficient and clean introduction of functionalized alkyl groups
Egle, B.; Munoz, J.; Alonso, N.; De Borggraeve, W. M., de la Hoz, A.; Diaz-Ortiz, A.; Alcazar, J.; J. Flow Chem., 2014, 4(1), 22-25
Discovery of N-[[1-[2-(tert-butylcarbamoylamino)ethyl]-4-(hydroxymethyl)-4-piperidyl]methyl]-3,5-dichloro-benzamide as a selective T-type calcium channel (Cav3.2) inhibitor
Giordanetto, F.; Wallberg, A.; Knerr, L.; Selmi, N.; Ullah, V.; Thorstensson, F.; Lindelof, L.; Karlsson, S.; Nikitidis, G.; Llinas, A.; Wang, Q. D.; Lindqvist, A.; Hogberg, L.; Lindhardt, E.; Astrand, A.; Duker, G.; Bioorg. Med. Chem. Lett., 2013, 23(1), 119-124
Increasing selectivity of CC chemokine receptor 8 antagonists by engineering nondesolvation related interactions with the intended and off-target binding sites
Shamovsky, I.; de Graaf, C.; Alderin, L.; Bengtsson, M.; Bladh, H.; Börjesson, L.; Connolly, S.; Dyke, H. J.; van den Heuvel, M.; Johansson, H.; Josefsson, B.; Kristoffersson, A.; Linnanen, T.; Lisius, A.; Mannikko, R.; Norden, B.; Price, S.; Ripa, L.; Rognan, D.; Rosendahl, A.; Skrinjar, M.; Urbahns, K.; J. Med. Chem., 2009, 52, 7706-7723
Synthesis of new 18F-radiolabeled silicon-based nitroimidazole compounds
Joyard, Y.; Azzouz, R.; Bischoff, L.; Papamicael, C.; Labar, D.; Bol, A.; Bol, V.; Vera, P.; Gregoire, V.; Levacher, V.; Bohn, P.; Bioorg. Med. Chem., 2013, 21, 3680-3688
Synthesis, in vivo occupancy, and radiolabeling of potent phosphodiesterase subtype-10 inhibitors as candidates for positron emission tomography imaging
Andres, J-I.; De Angelis, M.; Alcazar, J.; Iturrino, L.; Langlois, X.; Dedeurwaerdere, S.; Lenaerts, I.; Vanhoof, G.; Celen, S.; Bormans, G.; J. Med. Chem., 2011, 54, 5820-5835
Discovery and synthesis of hydronaphthoquinones as novel proteasome inhibitors
Ge, Y.; Kazi, A.; Marsilio, F.; Luo, Y.; Jain. S.; Brooks, W.; Daniel, K. G.; Guida, W. C.; Sebti, S. M.; Lawrence, H. R.; J. Med. Chem., 2012, 55(5), 1978-1998
Structure-based design of potent and ligand-efficient inhibitors of CTX-M class A β-lactamase
Nichols, D. A.; Jaishankar, P.; Larson, W.; Smith, E.; Liu, G.; Beyrouthy, R.; Bonnet, R.; Renslo, A. R.; Chen, Y.; J. Med. Chem., 2012, 55(5), 2163-2172